BioNTech Valuation
| 22UA Stock | EUR 89.75 0.75 0.84% |
At this time, the firm appears to be overvalued. BioNTech SE shows a prevailing Real Value of €75.47 per share. The current price of the firm is €89.75. Our model approximates the value of BioNTech SE from analyzing the firm fundamentals such as Return On Equity of -0.0304, profit margin of (0.18) %, and Current Valuation of 8.07 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting BioNTech's valuation include:
Price Book 1.2087 | Enterprise Value | Enterprise Value Ebitda 47.2463 | Price Sales 7.1439 | Forward PE 7.2359 |
Overvalued
Today
Please note that BioNTech's price fluctuation is very steady at this time. Calculation of the real value of BioNTech SE is based on 3 months time horizon. Increasing BioNTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioNTech stock is determined by what a typical buyer is willing to pay for full or partial control of BioNTech SE. Since BioNTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioNTech Stock. However, BioNTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 89.75 | Real 75.47 | Hype 89.86 |
The real value of BioNTech Stock, also known as its intrinsic value, is the underlying worth of BioNTech SE Company, which is reflected in its stock price. It is based on BioNTech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioNTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioNTech SE helps investors to forecast how BioNTech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioNTech more accurately as focusing exclusively on BioNTech's fundamentals will not take into account other important factors: When choosing an evaluation method for BioNTech SE, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
BioNTech Cash |
|
About BioNTech Valuation
The stock valuation mechanism determines BioNTech's current worth on a weekly basis. Our valuation model uses a comparative analysis of BioNTech. We calculate exposure to BioNTech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioNTech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.5 B | 4.7 B | |
| Pretax Profit Margin | (0.22) | (0.23) | |
| Operating Profit Margin | (0.43) | (0.41) | |
| Net Loss | (0.22) | (0.23) | |
| Gross Profit Margin | 0.72 | 0.76 |
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |